Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma

NCT00052390 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: bevacizumab
DRUG: doxorubicin hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]